Microbiology
Showing page 174 of 255 pages of list content
-
SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways
This article's authors -
SARS-CoV-2 Variants Reveal Features Critical for Replication in Primary Human Cells
This article's authors -
Identification of TMEM106B as proviral host factor for SARS-CoV-2
This article's authors -
Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without
This article's authors -
Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical in silico/in vitro screening methods
This article's authors -
Lopinavir-ritonavir is not an effective inhibitor of the main protease activity of SARS-CoV-2 in vitro
This article's authors -
Elucidating the antiviral mechanism of different MARCH factors
This article's authors -
Methylene Blue has a potent antiviral activity against SARS-CoV-2 in the absence of UV-activation in vitro
This article's authors -
Effect of mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion function
This article's authors -
A potent SARS-CoV-2 neutralizing human monoclonal antibody that reduces viral burden and disease severity in Syrian hamsters
This article's authors